Research progress of Ganoderma lucidum polysaccharide in prevention and treatment of Atherosclerosis
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2022MH208)
This publication has 84 references indexed in Scilit:
- Empagliflozin ameliorates atherosclerosis via regulating the intestinal floraAtherosclerosis, 2023
- LDL and HDL Oxidative Modification and Atherosclerosis2020
- Notch signaling at the crossroads of innate and adaptive immunityJournal of Leukocyte Biology, 2020
- Galectin‐3 aggravates ox‐LDL‐induced endothelial dysfunction through LOX‐1 mediated signaling pathwayEnvironmental Toxicology, 2019
- Overview of Ganoderma sinense polysaccharide–an adjunctive drug used during concurrent Chemo/Radiation therapy for cancer treatment in ChinaBiomedicine & Pharmacotherapy, 2017
- The improvement of M1 polarization in macrophages by glycopeptide derived from Ganoderma lucidumImmunologic Research, 2017
- Differential regulation of macrophage inflammatory activation by fibrin and fibrinogenActa Biomaterialia, 2017
- Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient miceAtherosclerosis, 2013
- Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic miceArchives of Pharmacal Research, 2012
- Reendothelialization and maintenance of endothelial integrity in longitudinal denuded tracks in the thoracic aorta of ratsAtherosclerosis, 1983